Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Naoko Wada"'
Autor:
Kanako Sumi, Yuiko Hatanaka, Reina Takahashi, Naoko Wada, Chihiro Ono, Yuri Sakamoto, Hirohito Sone, Kaoruko Iida
Publikováno v:
Frontiers in Nutrition, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/2d01e161531e495e8a9e29e844b41b9b
Autor:
Kanako Sumi, Yuiko Hatanaka, Reina Takahashi, Naoko Wada, Chihiro Ono, Yuri Sakamoto, Hirohito Sone, Kaoruko Iida
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
A decrease in TCA cycle activity may lead to impaired nutrition metabolism and cellular energy shortage. Herein, we aimed to characterize the detailed metabolic changes that compensate for energy shortages in energy-consuming organs (heart and skelet
Externí odkaz:
https://doaj.org/article/b8845e0d306245f38add216ea92c8445
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
With the renewed interest in low-carbohydrate diets (LCDs) in the sports field, a few animal studies have investigated their potential. However, most rodent studies have used an LCD containing low protein, which does not recapitulate a human LCD, and
Externí odkaz:
https://doaj.org/article/83ed923d5edf48a8854dfcc5c3e08cc7
Autor:
Seiichi Yano, Kenji Ashida, Hiromi Nagata, Kenji Ohe, Naoko Wada, Yukina Takeichi, Yuki Hanada, Yuta Ibayashi, Lixiang Wang, Shohei Sakamoto, Ryuichi Sakamoto, Hiroshi Uchi, Motoaki Shiratsuchi, Masutaka Furue, Masatoshi Nomura, Yoshihiro Ogawa
Publikováno v:
BMC Endocrine Disorders, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Nivolumab, an anti-programmed cell death-1 monoclonal antibody, has improved the survival of patients with malignant melanoma. Despite its efficacy, nivolumab inconsistently induces thyroid dysfunction as an immune-related adverse
Externí odkaz:
https://doaj.org/article/5bd2e9d380954684be3d0d0d2083d326
Autor:
Taku Fujimura, Yota Sato, Kayo Tanita, Chunbing Lyu, Yumi Kambayashi, Ryo Amagai, Atsushi Otsuka, Yasuhiro Fujisawa, Koji Yoshino, Shigeto Matsushita, Hiroshi Uchi, Yuki Yamamoto, Hiroo Hata, Takeru Funakoshi, Yumi Nonomura, Ryota Tanaka, Hisako Okuhira, Naoko Wada, Akira Hashimoto, Setsuya Aiba
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
Anti-programmed cell death protein 1 (PD1) antibodies are in wide use for the treatment of various cancers. PD1 antibody-based immunotherapy, co-administration of nivolumab and ipilimumab, is one of the optimal immunotherapies, especially in advanced
Externí odkaz:
https://doaj.org/article/60775cb304df4e02a56684d41b7ab84f
Autor:
Hisashi Nomura, Naoko Wada, Hayato Takahashi, Yuko Kase, Jun Yamagami, Shohei Egami, Hisato Iriki, Miho Mukai, Aki Kamata, Hiromi Ito, Hideki Fujii, Tomoyuki Ishikura, Haruhiko Koseki, Takashi Watanabe, Taketo Yamada, Osamu Ohara, Shigeo Koyasu, Masayuki Amagai
Publikováno v:
The Journal of Immunology. 208:582-593
Pemphigus vulgaris is an autoimmune blistering disease caused by IgG targeting desmoglein 3 (Dsg3), an adhesion molecule of keratinocytes. Anti-Dsg3 IgG production is prevented in healthy individuals, but it is unclear how Dsg3-specific B cells are r
Autor:
Arisa Takasugi, Naoko Wada
Publikováno v:
Journal of the Japan Organization of Clinical Dermatologists. 39:578-582
Autor:
Yuya Akagi, Kei Kamide, Mai Kabayama, Shin Takiuchi, Ken Sugimoto, Koichi Yamamoto, Michio Tamatani, Ayumi Shintani, Yukako Nakata, Hiromi Rakugi, Jun Tomita, Atsuko Higuchi, Naoko Wada
Publikováno v:
American Journal of Hypertension
Background To evaluate the effectiveness of the nurse-led alcohol guidance to control home blood pressure (HBP) in the morning among male patients with hypertension during outpatient visits. Methods We enrolled 53 male patients with an HBP of ≥135/
Autor:
Masayuki Amagai, Osamu Nureki, Naoko Wada, Yutaka Kurebayashi, Jun Yamagami, Akihiko Yoshimura, Shohei Hori, Hisashi Nomura, Hiromi Ito, Miho Mukai, Hiroshi Nishimasu, Takeshi Matsui, Setsuko Mise-Omata, Hayato Takahashi, Aki Kamata, Hisato Iriki
Publikováno v:
Proc Natl Acad Sci U S A
Antigen-specific peripheral tolerance is crucial to prevent the development of organ-specific autoimmunity. However, its function decoupled from thymic tolerance remains unclear. We used desmoglein 3 (Dsg3), a pemphigus antigen expressed in keratinoc
Autor:
Masutaka Furue, Hiroshi Uchi, Nao Hasuzawa, Seiichi Yano, Shohei Sakamoto, Masatoshi Nomura, Naoko Wada, Kenji Ohe, Kenji Ashida, Chihiro Sakaguchi, Yayoi Matsuda, Yoshihiro Ogawa, Ryuichi Sakamoto
Publikováno v:
Current Oncology
Volume 26
Issue 1
Pages 4130-118
Volume 26
Issue 1
Pages 4130-118
Nivolumab, an anti&ndash
PD-1 antibody, is now considered an important therapeutic agent in several advanced malignancies. However, immune-related adverse events such as endocrinopathies have been reported with its use. Thyroid disorder and isol
PD-1 antibody, is now considered an important therapeutic agent in several advanced malignancies. However, immune-related adverse events such as endocrinopathies have been reported with its use. Thyroid disorder and isol